FDA
approval
· 2023-10-24
FDA Approved: VESTURA — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
The FDA approved a supplemental application for VESTURA (drospirenone and ethinyl estradiol) from Teva, updating labeling to support its use as a combined oral …
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VESTURA (DROSPIRENONE AND ETHINYL ESTRADIOL)